ºÚÁϳԹÏÈºÍø

Clinical Services

Research reveals likely locations of next pandemic

27 November, 2020

An international team of human and animal health experts has identified areas at risk of harbouring the conditions that may lead to the next pandemic.


AstraZeneca vaccine candidate

26 November, 2020 by Nicholas Wood, University of Sydney for The Conversation

AstraZeneca's results signal more good vaccine news — but efficacy is only the beginning of the story.


Australian surgeons gain access to surgical wash to combat post-surgical infection

25 November, 2020

Next Science has announced the Australian launch of Bactisure — a surgical wash that combats post-surgical infections and helps to address antibiotic resistance.


SHPA Virtual Congress award winners announced

25 November, 2020

The Society of ºÚÁϳԹÏÈºÍø Pharmacists of Australia (SHPA) has hosted a successful, celebratory and all-virtual 2020 SHPA Virtual Congress.


Monash superbug project to mobilise genomics, digital health and AI

23 November, 2020

The innovative project will integrate genomics, electronic healthcare data and AI technologies to address antimicrobial resistance in the healthcare system.


Tool helps manage pain in dementia residents

20 November, 2020

A tech partnership means that carers can now access a tool to help identify, monitor and reduce pain in dementia aged-care residents.


Interim results: Moderna vaccine candidate stable and effective

20 November, 2020

Interim analysis of Moderna's Phase 3 study of mRNA-1273 finds that the COVID-19 vaccine candidate has an efficacy of 94.5% and remains stable at -20°C for up to six months.


Drug-resistant UTIs: the canary in the coalmine

19 November, 2020

One of the world's most common infections will cost Australia more than $1 billion a year within the next decade if nothing is done to stop the rise of antibiotic-resistant bacteria.


Pregnant and postpartum women with COVID-19 are at risk of blood clotting

17 November, 2020 by Amy Sarcevic

Pregnant women who contract COVID-19 may be at higher risk of blood clotting, especially those who become severely ill with the virus, says Associate Professor Sanjaya Senanayake of the Australian National University.


How did Royal Melbourne ºÚÁϳԹÏÈºÍø curb its COVID-19 outbreak?

16 November, 2020

Reported to have endured the largest institutional outbreak of COVID-19 in healthcare workers in Australia, the RMH's multidimensional response has been examined.


Vaccinate potential superspreaders first, researchers say

13 November, 2020

Macquarie University researchers have unveiled a strategy that models who should be vaccinated first.


Partners take on cancer and heart disease

13 November, 2020

GE Healthcare and GenesisCare have partnered to tackle the globe's greatest health burdens: cancer and cardiovascular disease.


Australian experts respond to Pfizer vaccine announcement

12 November, 2020

Pfizer and BioNTech have issued a press release, announcing that their vaccine candidate is more than 90% effective in preventing COVID-19.


Research uncovers the hidden path of breast cancers

11 November, 2020

The secret pathway used by some aggressive breast cancers to avoid detection has been uncovered by researchers at Macquarie University.


School poisoning incidence calls for improved safety

09 November, 2020

Child and adolescent exposure to poisoning while at school is relatively common and appears to be increasing, according to research from the University of Sydney.



Content from other channels on our network


  • All content Copyright © 2025 ºÚÁϳԹÏÈºÍø-Farrow Pty Ltd